Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Congress Unlikely To Weaken Orphan Exemption To Price Negotiation Despite Higher Cost Projections
Oct 22 2025
•
By
Cathy Kelly
Proponents of the change believe the higher costs still are beneficial.
(Shutterstock)
More from Medicare
More from Government Payers